Articles

Find an Article

Filter articles

Showing 1 to 10 of 425 results

Levelling the SPC playing field

EU19-05-2017Allison Sadick

Medical technology companies should not be left out of discussions in Europe about modernising the system for supplementary protection certificates, argues Allison Sadick of Pinsent Masons.

ANVISA and INPI: the end of an impasse?

Brazil25-04-2017Breno Souza, Luisa Rezende and Silvia Costa

A disagreement over how pharma patents in Brazil are examined seems to have come to an end, as Breno Souza, Luisa Rezende and Silvia Costa of Clarke Modet & Co Brazil report.

Plants, patents and political challenges

EU04-04-2017Jane Wainwright

European developments surrounding the patentability of plants and animals have become rather political, but there are ways for patentees to mitigate the effects of political influence over the patenting process, writes Jane Wainwright of Potter Clarkson.

New rules for SPCs in Spain

Spain27-03-2017José Manuel González

A new law on supplementary protection certificates will be implemented on April 1, with the application, prosecution and maintenance of SPCs taking centre stage. José Manuel González of Clarke, Modet & Co reports.

TPP abandonment: the fallout for biotech and pharma

US15-03-2017Kevin Noonan

President Trump’s decision to pull the US out of the Trans-Pacific Partnership trade deal may have particularly pernicious consequences for the pharmaceutical and biotechnology industries, writes Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff.

Patent eligibility for healthcare IT applications

US23-02-2017Stacy Taylor

As securing patent eligibility for ‘healthcare IT’ applications seems to be becoming easier, companies looking to monetise IP in this area can breathe a sigh of relief. Stacy Taylor of DLA Piper explains more.

Licensing tips from a patent litigator

US21-02-2017Jessamyn Berniker

Anyone drafting patent licence agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.

Biosimilars in Italy: a new regime

Italy10-01-2017Luca Tosoni

Several changes have been made to Italy’s regulatory landscape for biosimilars, as Luca Tosoni of Covington & Burling reports.

New technologies, old framework: maximising IP protection for 3D printing in the life sciences

US05-01-2017Arlene Chow and Nitya Anand

IP law has yet to catch up with the technological capabilities of 3D printing, but by taking pre-emptive action, companies can maximise their IP protection under the current legal framework. Arlene Chow and Nitya Anand of Hogan Lovells report.

The pitfalls of second medical use patents

UK03-01-2017Geoff Hussey and Christopher Burnett

It appears necessary and perhaps inevitable that further guidance from the UK Court of Appeal will be provided on the issue of second medical use patents, following the high-profile dispute between Warner-Lambert and Actavis. Geoff Hussey and Christopher Burnett of AA Thornton & Co report.

Showing 1 to 10 of 425 results

LSIPR